Treatment Of Idiopathic Pulmonary Fibrosis (ipf) With Laparoscopic Anti-Reflux Surgery (lars) Is Associated With Improvement In Forced Vital Capacity (FVC)

被引：0
|
作者：
Raghu, G. [1 ]
Mart, D. [1 ]
Anstrom, K. J. [2 ]
Hinojosa, M. [1 ]
Hayes, J. [1 ]
Spada, C. [1 ]
Oelschlager, B. [1 ]
Pellegrini, C. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Duke Univ, Durham, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5711
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect Of Nintedanib On Decline In Forced Vital Capacity (FVC) Over Time In The Inpulsis® Trials In Patients With Idiopathic Pulmonary Fibrosis
    Maher, T. M.
    Flaherty, K. R.
    Azuma, A.
    Cottin, V.
    Stansen, W.
    Quaresma, M.
    Wells, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [22] Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib
    Mondoni, Michele
    Varone, Francesco
    Alfano, Fausta
    Muscato, Giuseppe
    Conti, Caterina
    Saderi, Laura
    Iovene, Bruno
    Di Marco, Fabiano
    Vancheri, Carlo
    Richeldi, Luca
    Centanni, Stefano
    Sotgiu, Giovanni
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (07): : 464 - 466
  • [23] Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis
    Pesonen, Ida
    Gao, Jing
    Kalafatis, Dimitrios
    Carlson, Lisa
    Myllarniemi, Marjukka
    Ferrara, Giovanni
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis
    Behr, J.
    Bonella, F.
    Bonnet, R.
    Glaeser, S.
    Grohe, C.
    Guenther, A.
    Koschel, D.
    Kreuter, M.
    Kirsten, D.
    Kroegel, C.
    Markart, P.
    Mueller-Quernheim, J.
    Neurohr, C.
    Pfeifer, M.
    Prasse, A.
    Schoenfeld, N.
    Schreiber, J.
    Wirtz, H.
    Witt, C.
    Costabel, U.
    PNEUMOLOGIE, 2015, 69 (08): : 455 - 458
  • [25] Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
    Bermudo, Guadalupe
    Suarez-Cuartin, Guillermo
    Rivera-Ortega, Pilar
    Rodriguez-Portal, Jose Antonio
    Sauleda, Jaume
    Nunez, Belen
    Castillo, Diego
    Aburto, Myriam
    Portillo, Karina
    Balcells, Eva
    Badenes-Bonet, Diana
    Valenzuela, Claudia
    Fernandez-Fabrellas, Estrella
    Gonzalez-Budino, Teresa
    Cano, Esteban
    Acosta, Orlando
    Leiro-Fernandez, Virginia
    Romero, Ana
    Planas-Cerezales, Lurdes
    Villar, Ana
    Moreno, Amalia
    Laporta, Rosalia
    Vicens-Zygmunt, Vanesa
    Shull, Jessica
    Franquet, Tomas
    Luburich, Patricio
    Molina-Molina, Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (02): : 135 - 141
  • [26] The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis
    Assayag, D.
    Vittinghoff, E.
    Ryerson, C. J.
    Cocconcelli, E.
    Tonelli, R.
    Elicker, B.
    Golden, J.
    Jones, K. D.
    King, T. E.
    Koth, L. L.
    Lee, J. S.
    Ley, B.
    Wolters, P. J.
    Collard, H. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis
    Paterniti, Miya O.
    Bi, Youwei
    Rekic, Dinko
    Wang, Yaning
    Karimi-Shah, Banu A.
    Chowdhury, Badrul A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (09) : 1395 - 1402
  • [28] Effect Of Continued Treatment With Pirfenidone Following A Clinically Meaningful Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Nathan, S. D.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Du Bois, R. M.
    Fagan, E. A.
    Glaspole, I.
    Glassberg, M. K.
    King, T. E.
    Lancaster, L.
    Lederer, D. J.
    Lin, Z.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [29] Effect Of Continued Treatment With Pirfenidone Following A ≥10% Relative Decline In Percent Predicted Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis (ipf)
    Nathan, S. D.
    Albera, C.
    Costabel, U.
    Glaspole, I.
    Glassberg, M.
    Lancaster, L.
    Lederer, D. J.
    Pereira, C. A.
    Swigris, J.
    Day, B. -M.
    Chou, W.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] EFFECT OF CONTINUED TREATMENT WITH PIRFENIDONE FOLLOWING A CLINICALLY MEANINGFUL DECLINE IN PERCENT PREDICTED FORCED VITAL CAPACITY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Noble, P. W.
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Glaspole, I.
    Glassberg, M. K.
    Lancaster, L.
    Lederer, D. J.
    Lin, Z.
    Pereira, C. A.
    Swigris, J. J.
    Valeyre, D.
    Nathan, S. D.
    THORAX, 2015, 70 : A62 - A63
12345